Full-Time
Research Associate I
Protein Science & Analytics
Posted on 8/17/2026
Every
51-200 employees
Animal-free protein ingredients via precision fermentation
Compensation Overview
$75k - $85k/yr
No H1B Sponsorship
San Francisco, CA, USA
In Person
Bachelor's
 Biology & Biotech (1) |
|---|
Get referred to Every
See people who can refer or advise you
- A bachelor's degree in Biology, Biochemistry, Chemistry, or a related field is required.
- Some hands-on laboratory experience from academic, internship, or industry settings, with familiarity with analytical instrumentation, is required.
- The candidate must be able to take detailed experiment notes, write reports, and communicate experimental results to team members.
- The candidate must be comfortable with basic wet-lab techniques, especially pipetting with single- and multichannel pipettes.
- The candidate must be collaborative, organized, and enthusiastic about working across teams.
- Generate data using basic biochemistry and molecular biology techniques, including BCA and SDS-PAGE.
- Operate and maintain analytical equipment, including HPLC-UV/RI, Combustion Analyzer, dynamic light scatterer, FPLC-UV, and fluorescence/UV plate reader.
- Support protein-characterization workflows through lab-scale protein-powder generation involving bench-scale downstream-processing unit operations such as microfiltration, ultrafiltration, and diafiltration.
- Prepare samples, reagents, and buffers for cross-functional experiments.
- Collaborate with scientists and engineers across teams to troubleshoot and iterate as part of the Design, Build, Test, and Learn pipeline.
- Present results to the technology organization in regular scientific-team meetings.
- Maintain laboratory organization, cleanliness, and proper documentation.
The EVERY Company creates animal-free protein, especially vegan egg protein, using precision fermentation to produce high-quality ingredients for food and beverage brands. Its products are not finished consumer foods but protein ingredients that manufacturers incorporate into vegan-friendly foods such as beverages and baked goods. The process works by using precision fermentation to grow microbial systems that produce specific proteins, which are then harvested and processed into usable ingredients. The company distinguishes itself through strategic B2B partnerships with large players like Ingredion and AB InBev BioBrew, enabling global distribution and scale, rather than competing as a consumer-brand producer. The goal is to supply scalable, sustainable, ethical protein ingredients to food brands, helping them meet rising demand for plant-based and animal-free options.
Company Size
51-200
Company Stage
Series D
Total Funding
$308.8M
Headquarters
Daly City, California
Founded
2014
Get referred to Every
See people who can refer or advise you
Simplify's Take
What believers are saying
- Huvepharma quadrupled capacity on June 15, 2026, after 550% order growth.
- Target joined Walmart nationwide in 2026, validating mass-market grocery adoption.
- Healthier Comforts launched consumer OvoPro powder in March 2026, opening direct-to-consumer demand.
What critics are saying
- Delaware litigation with Onego Bio threatens Patent 12,096,784 and EVERY’s moat.
- EU approvals remain pending in 2026, blocking Palacios and broader international rollout.
- If chicken egg prices normalize, retailers abandon premium OvoPro and crush demand.
What makes Every unique
- OvoPro is the first commercially available fermentation-made egg protein, not a plant mimic.
- EVERY sells functional ovalbumin, enabling whipping, binding, foaming, and gelling.
- It bridges B2B ingredients and retail products through Walmart, Target, and Healthier Comforts.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
Paid Holidays
Commuter Benefits
Wellness Program
Gym Membership
401(k) Company Match
Stock Options
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 2%2 year growth
↑ 6%The EVERY Company has appointed Mario Patiño as its first Chief Revenue Officer following its nationwide expansion into Walmart and Target stores. The San Francisco-based precision-fermentation startup produces animal-free protein ingredients for the food industry. Patiño joins from Insight M, where he served as CRO and built international business strategy. He has previously closed over $250 million in customer contracts and built multi-billion dollar pipelines whilst commercialising novel technologies at scale. As CRO, Patiño will drive US mass market adoption, lead global expansion into Latin America, EMEA and Asia-Pacific, and scale commercial infrastructure to meet demand for EVERY's flagship OvoPro product. The appointment follows the company's recent Series D funding round and marks an inflection point as EVERY transitions from concept validation to global scale.
The EVERY Company is supplying its precision-fermented egg white protein, OvoPro™, to Healthier Comforts for the first time, making the ingredient available to consumers. Healthier Comforts' Animal-Free Egg White Protein Powder launches on its website and Amazon in an 8oz resealable bag designed for home cooking and baking. Previously available only to food manufacturers in bulk, OvoPro™ addresses a gap in the vegan market for functional egg white replacements suitable for meringues, macarons and angel food cake. The product soft-launched in December 2025 and sold out quickly after gaining attention in vegan communities on Reddit. The partnership began when Healthier Comforts founder Aaron Vander Heyden met EVERY at IFT First in Chicago, recognising the potential to serve home cooks with a retail-ready format.
The EVERY Company, a biotechnology leader pioneering precision fermentation for highly functional proteins, today announced that it has successfully closed o...
The Every Company has raised $55 million in a Series D funding round.
USA - The EVERY Company, a biotechnology firm specializing in animal-free proteins, has received US$2 million in funding from the United States Department o ...